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Can the Critical Appraisal Skills Programme check-lists (CASP) be used alongside GRADE 





The Grading of Recommendations Assessment, Development, and Evaluation Working Group 
Guidance is widely used to increase the transparency by which evidence is turned into 
recommendations.  However, although the process is clearly defined, it may be difficult to use in 
nursing education and practice because it uses separate terminology and tools to those sometimes 
used in education, such as those devised by the Critical Appraisal Skills Programme.  This paper 
aims to show how these tools can be used together. 
Design:  
Discussion paper. 
Data Sources:  
Documentation from the Grading of Recommendations Assessment, Development, and Evaluation 
Working Group and the Critical Appraisal Skills Programme, as of 14th June 2019. 
Implications for Nursing:  
All of the items from the Critical Appraisal Skills Programme check-list can be incorporated into 
GRADE which might allow for wider use of its principles in nursing education and practice.  Some 
additions are required however to complete the outcome-level assessment, these being the 
consistency of the results and possible publication bias.  More detail on the extent to which the 
benefits are worth any harms and costs, and different types of inconsistency (heterogeneity) would 
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also be useful. This approach is consistent with the Group’s Criteria for determining whether the 
GRADE approach was used. 
Conclusion:  
The Critical Appraisal Skills Programme tool can be used with minor modification to in a GRADE-
like manner.  This would allow for GRADE to be taught and used in nursing education and 
transferred to practice. 
Impact: 
• This discussion paper addressed the use of the Critical Appraisal Skills Programme 
Randomised Controlled Trial checklist to undertake GRADE-like assessments of evidence. 
• With minor modifications to the way CASP is used, it is possible to use this tool to make 
GRADE-like assessments of the body of evidence as well as to critique individual studies. 
• This finding will allow for the full use of the GRADE approach in healthcare education 
using the Critical Appraisal Skills Programme tools. 
 
Keywords: CASP; Guideline; GRADE approach [MeSH]; Nursing practice; Nursing theory; 













The number of systematic reviews and clinical guidelines that are being written and published has 
increased greatly in recent years. Transparency in all aspects of research and clinical decision-
making is universally recognised as being important, hence the development of a number of 
standardised study, review and guideline methodologies and reporting standards (Wager & Kleinert, 
2013).  While the use of guidance in clinical practice is explicitly not mandated, the British National 
Institute for Health and Care Excellence (NICE) for example stating that “it is not mandatory to 
apply [the] recommendations”(NICE, 2013); not following what is accepted as best practice 
through guidance can lead to criticism if negative outcomes result (Mellor, 2014). As important 
patient decisions and clinical judgements are made using them, the process by which guidelines are 
developed and recommendations made is therefore of utmost importance. 
 
Background 
It is argued by some that in order for nursing to be considered a profession, it must posses a unique 
perspective and have an identifiable and distinct body of knowledge that is researched, developed 
and advanced as it is passed on through the members of the nursing profession (Moulton, Wilson, 
Camargo Plazas, & Halverson, 2019).  However, the development of such a body of knowledge in a 
discipline such as nursing which uses evidence from a wide variety of other professions such as 
medicine, psychology and sociology is not straightforward; and it may not the the knowledge that is 
unique, but rather the perspective with which that knowledge is applied (Mckenna, 1993).  It has 
recently been suggested that the fundamental question for nursing research should be around how 
the well-being of people, families, communities or populations can be improved? (Moulton et al., 
2019).  The development of nursing research and the use of evidence by nurses to improve patient 
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outcomes is thought by many to have started with Florence Nightingale in the 1850s, and over time 
the nature and focus of nursing research has changed.  More recently we have seen an increasing 
emphasis upon evidence-based practice and systematic reviews, perhaps best exemplified by the 
development of the Cochrane Collaboration in 1993, the Joanna Briggs Institute in 1996 and the 
Campbell Collaboration in 1999. 
 
The lack of a distinct body of literature and the multiplicity of different methods that are used to 
examine questions that are of interest to nurses poses a significant problem, which is that it is 
impossible for researchers and practitioners to be expert in all of the methods used by researchers, 
even if they wished.  Furthermore, the growth in the number of research papers and the variety 
forms in which they are published may make it difficult for nurses to keep abreast of new 
developments.  Many appraisal tools and check-lists have been developed to help nurses understand 
the research they are reading (Buccheri & Sharifi, 2017) including those developed by some of the 
organisations above.  Such diversity of tools is not restricted to quantitative research, a recent study 
of tools designed specifically appraise the quality of quantitative research found 102 different tools 
covering a total of 22 themes (Munthe-Kaas, Glenton, Booth, Noyes, & Lewin, 2019). 
 
Despite the fact that historically hierarchies of evidence have emphasised randomised controlled 
trials as being the highest level of evidence (Burns, Rohrich, & Chung, 2011), application of 
evidence to practice and sound decision-making requires a systematic review of all of the literature 
in order to make informed judgements; thus in contemporary hierarchies the highest level of 
evidence for most clinical questions is not an individual study, but rather a systematic review of 
studies (Oxford Centre for Evidence-Based Medicine, 2016).  Although qualitative research is 
different in many ways to quantitative methods, equivalent hierarchies do exist (Daly et al., 2007a), 
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and systematic review methodologies for qualitative and mixed-methods are also seen as being 
increasingly important (Barnett-Page & Thomas, 2009; Gough, 2015).  
 
Although many clinical decisions are made on the basis of evidence from formal systematic reviews 
or guidance produced by national bodies and specialist groups, others are made on a more local 
basis or by those with fewer resources than large review or guidance producing organisations.  
While it is important that systematic reviews are undertaken using a standard methodology to 
ensure rigour, the number of tools and check-lists involved in this process has made this 
increasingly complex; these include reporting guidelines for studies, risk of bias tools, evidence 
summary tools and reporting guidelines for systematic reviews themselves (Moher, Liberati, 
Tetzlaff, Altman, & The PRISMA Group, 2009; Whiting et al., 2016).  Additionally the number and 
complexity of some of these tools appear to be increasing, with the Cochrane Risk of Bias Tool 2 
for randomised controlled trials being more complex than the original tool; and a different tool 
being required for non-random studies for example (Cochrane Methods, 2019). 
 
Although sometimes thought to be a single action, ‘critical appraisal’ is actually a linear process that 
is comprised of a number of related but distinct parts, these being appraisal of: 
1. The quality of reporting for each study 
2. The conduct of each study 
3. The risk of bias of each study 
4. The body of evidence; that is all of the studies together for each outcome.  This includes the 
risk of bias and other factors. 
5. The appraised evidence then needs to be transformed in to logical and transparent 
recommendations.   
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The first three of these are study-level decisions, while the fourth and fifth are outcome level ones 
reflecting decisions made across all of the studies that are contributing to that outcome.  
Transparency throughout this process is of the upmost importance so that the rationale for decisions 
can be understood.  The importance of this can be seen in review and guideline methodologies; 
explicit inclusion of equalities statements; the increasing publication of original data; and the wider 
involvement of patients and other stakeholders. 
 
The quality of reporting is quite distinct from the quality of the study, and so will not be considered 
here apart to note that there are numerous reporting tools which can be found on the Enhancing the 
QUAlity and Transparency Of health Research or EQUATOR Network webpage 
(http://www.equator-network.org/).  In terms of appraising individual studies as opposed to their 
reporting there are two distinct concepts within this, that of the conduct of the study and the related 
but distinct idea of the risk of bias associated with the study.  In the Cochrane Handbook it is the 
latter that is emphasised; that is “the extent to which the results can be believed” (Higgins & Green, 
2011).  The risk of bias needs to be assessed at both study and review-level, the latter being 
necessary as part of the process to assess the overall body of evidence used to come to a conclusion 
or make a recommendation.  Other tools such as the Critical Appraisal Skills Programme (CASP) 
Tools are commonly used for more general assessment of the conduct or quality of a study. 
 
The Critical Appraisal Skills Programme 
The Critical Appraisal Skills Programme system is well known to many healthcare practitioners as 
it is widely used as a pedagogical tool to critique studies and its use is taught in many undergraduate 
and post-gradate programmes, and the tools within CASP are similar in nature to those produced by 
a number of other organisations (Buccheri & Sharifi, 2017).  CASP comprises a number of check-
lists, each of which contains a number of questions presented in a systematic way to guide readers 
8 
through the appraisal process, including steps 1 to 3 above, but not the outcome-level steps 4 and 5 
(CASP, 2018). In addition to familiarity, it also has the advantage of having a number of different 
methodological check-lists, including those for different types of observational studies and 




The Grading of Recommendations Assessment, Development, and Evaluation 
The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) is a 
system that has been developed to be used to rate the quality of evidence in systematic reviews and 
guidelines, and then to grade the strength of recommendations made in guidelines in a transparent 
way (Guyatt et al., 2011).  It has a number of features that differentiate it from other similar 
systems, in particular that it is outcome-centric rather than study-based and that it separates  
judgements about the confidence in estimates or the quality of the evidence from judgements about 
the strength of recommendations that come from that evidence.  One rates the confidence in effect 
estimates, that is the quality of the evidence for each outcome, and uses this alongside other factors 
namely: the balance between desirable and undesirable outcomes; confidence in values and 
preferences and their variability; and resource use, to develop a nuanced recommendation that can 
be strong or weak and for or against a treatment option.  GRADE therefore defines the quality of 
evidence as the “extent to which our confidence in an estimate of the effect is adequate to support a 
particular recommendation” and uses this with these other factors to facilitate transparent decision 
making (GRADE, 2013).  Strong recommendations can therefore come from relatively weak 
evidence if factors such as the balance between desirable and undesirable consequences of the 
recommended action suggest this. 
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Although GRADE has been in existence for some time and has been widely adopted, this has 
primarily been used with quantitative outcomes.  A more recent initiative is GRADE-CERQual 
(Confidence in the Evidence from Reviews of Qualitative research); which seeks to fulfil a similar 
role with qualitative research (Lewin et al., 2018) but which is at a much earlier stage of 
development than GRADE or CASP.  Although hierarchies do exist for qualitative studies (Daly et 
al., 2007b), these are not universally recognised (JBI, 2019) and their use is somewhat less 
straightforward because qualitative study designs may not be so transparent or easy to identify 
(Buus & Agdal, 2013; McCrae & Purssell, 2016).  
 
The main criticisms surround the lack of theoretical and/or empirical justification for the GRADE 
criteria and lack of clarity regarding how some elements should be used in practice (Mercuri & 
Gafni, 2018a, 2018b, 2018c).  Although there has been copious words written on GRADE, in most 
cases it does still rely on consensus albeit from a large and growing user-base.  The authors suggest 
that until a stronger theoretical base can be provided “enthusiasm for the framework should be 
tempered” (Mercuri & Gafni, 2018c) (p. 1233).  While students should be encouraged to be critical 
of this and other similar frameworks, it is nonetheless one that they will come across and need to 
understand, the World Health Organization stating that for guideline development “while the ease of 
applying the GRADE approach will vary according to the type of evidence being assessed, the 
circumstances in which GRADE cannot be applied are rare”(World Health Organization, 2014) 
(p.121).  At the very least GRADE forces those making decisions to consider and to be transparent 
regarding important factors in decision-making, and organisations are adapting it to their specific 
needs within the broader requirements of the GRADE Working Group (Thornton et al., 2013).  
 
A criticism that can be explored with more advanced users is the theory that a Bayesian approach 
might be more appropriate, as this would allow one to incorporate prior knowledge and other 
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information into ones degree of belief in an outcome, the degree of belief being a Bayesian 
analogue to the confidence in the effect estimate.  The authors give the example of a single-large 
RCT  with a clear positive result, but then suggest that the prior knowledge that the results of many 
clinical studies are not reproducible might affect the degree of belief or confidence that one has in 
any given study result whatever the apparent methodological strength (Mercuri & Baigrie, 2018).  
This also reflects a wider debate about the relative merits of Bayesian versus  more traditional 
frequentist approaches to evidence (Gelman, 2008). 
 
Data sources 
Papers from the GRADE Working Group and supporting information; most data was taken from  




Use of CASP begins with identifying the type of study and choosing the correct checklist.  As an 
example the CASP checklist for RCTs comprises of a number of study-type specific questions 
designed to help readers consider the three broad issues that need to be considered when appraising 
a trial which come under three broad headings: 
1. “Are the results of the study valid?” 
2. “What are the results?” 
3. “Will the results help locally?” 
Thus the tool leads the user through the process of appraisal, beginning with three screening 
questions before asking “is it worth continuing?”  After this more detailed questions in each of the 
three categories are posed along with hints and areas for free-text comments.  In the case of the 
RCT tool there are a total of 11 questions. 
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Although these are designed to be study-level decisions, they could also be used to make a 
judgement across studies that would apply at the outcome level.  A comparison of the criteria used 
in the two systems are shown in Table 1; this shows that there are two GRADE criteria that are not 
reflected in CASP as they are specifically cross-study criteria, these being inconsistency of results 
and publication bias.  However CASP also contains a question on “how large was the treatment 
effect?”  This builds upon the GRADE strength of recommendation as adding an explicit statement 
about the strength of the effect enhances this judgement by being clear about how much benefit is 
likely to result (CASP, 2018). 
 
Using GRADE 
The GRADE process consists of a number of different steps: 
1. Defining the question and identifying important and critical outcomes 
2. Collecting evidence and generating an estimate of effect for each outcome  
3. Rating quality of evidence for each outcome 
4. Deciding on the direction and strength of each recommendation (Guyatt et al., 2011). 
 
The use of GRADE begins with formulating the question and identifying the important outcomes, 
before identifying the studies that can answer the question.  In studies of effectiveness randomized 
trials are seen to provide stronger evidence than non-randomised trials and observational studies, 
which in turn are evidentially stronger than uncontrolled studies such as case series and expert 
opinion.  However, unlike traditional hierarchies which have a rigid pyramid structure with 
randomised studies at the top, followed by prospective and retrospective observational studies, and 
then case series and expert opinion at the bottom (with systematic reviews of each type normally at 
the top of each of these); GRADE incorporates flexibility about this, thus the evidence provided by 
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a randomised trial may be downgraded and that from an observational study upgraded (Murad, Asi, 
Alsawas, & Alahdab, 2016).  Case-series which lack a control group are normally considered a low 
or very low level of evidence; while expert opinion is considered to be an interpretation of evidence 
rather than a direct form of evidence to be graded (GRADE, 2013). 
 
Randomised study evidence, which starts at a high level can be downgraded on the basis of risk of 
bias, inconsistency of the results, indirectness of the evidence, imprecision or publication bias.   
• Risk of bias is an assessment of possible “systematic error, or deviation from the truth, in 
results or inferences”(Higgins & Green, 2011), for which a number of different tools exist, 
including the questions within GRADE, those from the Cochrane Collaboration and 
elements of CASP.  The GRADE tool consists of five items: lack of allocation concealment, 
lack of blinding, incomplete accounting of patients and outcome events, selective outcome 
reporting and other factors. 
• Inconsistency of results refers to unexplained differences in study results, and is sometimes 
referred to as heterogeneity.   
• Indirectness occurs if the interventions, populations or other important factors are not 
identical to those in which one is interested.   
• Imprecision can be seen usually where sample sizes are small or the event of interest is very 
rare, leading to wide confidence intervals and uncertainty about the true effect.   
• Publication bias occurs when studies with particular results, for example those with a 
positive finding compared to those with a negative finding have a different probability of 
being published (GRADE, 2013).  
These elements of GRADE are mapped onto CASP in Table 1. 
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Observational studies on the other hand, which starts at a lower level, can be upgraded on the basis 
of: a large magnitude of effect; a dose-response gradient; or if all plausible residual confounding 
effects should reduce the demonstrated effect or increase the effect, if no effect was observed.   
There are also reasons that one might downgrade observational studies, these being: failure to 
develop and apply appropriate eligibility criteria; flawed measurement of both exposure and 
outcome; failure to adequately control confounding; and incomplete or inadequately short follow-up 
(GRADE, 2013). 
 
The important thing about GRADE is that these judgements are for the body of evidence as a whole 
(stage 4 above) rather than individual studies, although assessment of factors such as the risk of bias 
has to be undertaken at both study (stage 3) and outcome (stage 4) levels.  For this an appropriate 
tool must be used; GRADE provides one for RCTs but not other study-types.  A recent development 
has been the Risk Of Bias In Non-randomised Studies - of Interventions (ROBINS-I) which is 
currently being incorporated into GRADE (Schünemann et al., 2018; Sterne et al., 2016). 
 
Recommendations can then be made on the basis of this assessment of the strength of the evidence 
for each outcome, alongside a judgement about an assessment of the balance of desirable and 
undesirable consequences, the resource used, and values and preferences.  Recommendations 
should also have a strength, which reflects the extent to which a one is confident that the desirable 
effects of an intervention outweigh undesirable effects.  This constitutes stage 5.  A strong 
recommendation means that most people would benefit from the recommended course of action; 
while a weak one that it is thought to be beneficial but not all people would benefit from it; in the 
case of a negative recommendation these are adjusted accordingly.  GRADE also differentiates 
between guideline development and systematic reviewing with regards to making a 
recommendation, stating that the former but not the latter make decisions about what outcomes are 
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critical and the overall quality of evidence.  The extent to which this is true is perhaps debatable 
(GRADE, 2013). 
 
Can CASP be used to GRADE? 
The GRADE working-group rightly argues against the confusion that might come from using 
different systems for grading quality of evidence and strength of recommendations, however CASP 
could be used to support GRADE, and for clinicians who have learned CASP it may be more 
straightforward and easier to understand.  Furthermore its use would facilitate the use of the 
GRADE approach to students who might otherwise use informal or less transparent processes, and 
its transparency of decision-making may help to reduce the theory-practice gap (Purssell, 2019). 
 
Logically to fit in with the systematic approach to critical appraisal and support for evidence 
outlined above it might be helpful for CASP to be reorientated for this purpose as shown in Table 1, 
with those items that are study-orientated and those which are outcome orientated differentiated. 
Although those dealing with the risk of bias are applicable at study and outcome levels, the nature 
of the assessment is different with the outcome-level assessment being made on the weakest study 
used in judging each outcome.  Thus one might have a choice between more evidence but using 
weaker studies to support that, or a smaller number of stronger studies. 
 
Another advantage of using CASP is that it allows for systematic reviewers to make 
recommendations which GRADE does not allow.  This is because GRADE states that stakeholders 
are required to make valid judgements about the trade-offs between the desirable and undesirable 
consequences of a recommendation (Balshem et al., 2011).  Despite this systematic reviewers often 
do make recommendations with or without stakeholder involvement, the CASP items: can the 
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results be applied to the local population, or in your context? and are the benefits worth the harms 
and costs? being appropriately measured responses to this lack of stakeholder involvement. 
 
The main limitation of using CASP in this way is the lack of two important outcome-level criteria, 
those of the consistency of the results and possible publication bias.  These are important and need 
to be considered, and their absence results from CASP being tools developed to appriase individual 
studies rather than a body of evidence.  Additionally three GRADE criteria are are contained within 
the CASP question are the benefits worth the harms and costs?  It might be useful to be more 
specific about these (balance of desirable and undesirable consequences, resource use, and values 
and preferences).  It could be further improved by being clear about the different types of 
inconsistency or heterogeneity, these being: clinical differences and differences due to methodology, 
as well as simple differences in the results (Higgins & Green, 2011).  This would further encourage 
formal consideration not just of differences in the results, but of the methodology as well. 
 
The GRADE criteria for determining whether the GRADE approach was used is shown in Table 2; 
this demonstrating that use of CASP alongside a GRADE approach of assessing each study and then 
the overall body of evidence meets all of these criteria as long as two study-level criteria of 
inconsistency of results and publication bias are added.  In order to make the different levels of 
analysis clearer a slight reordering of the tool for this purpose might be helpful as outlined in Table 
1.   
 
Implications for nursing 
The advantage of this approach is that it allows the teaching of GRADE alongside CASP, 
introducing a widely used method to students and practitioners who might otherwise not be exposed 
to it.  Furthermore if GRADE is seen as a principal as well as a method, this approach is consistent 
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with the principles underlying GRADE.  Although GRADE has been criticised, it is widely used 
and the principle of transparent decision-making is important.  Furthermore extensions of GRADE 
such as the Evidence to Decision Frameworks are useful both in decision-making and 
understanding the complexity of practice recommendations by making it clear that evidence and 
research are not the only factors to be considered (Alonso-Coello et al., 2016). 
 
Conclusion 
This paper has shown how CASP can be adapted and used in a GRADE-like way.  This is important 
because GRADE is used by a large number of guideline development and other organisations, and 
introducing the approach to students and clinicians is important for them to understand how it 
works.  Although GRADE can be seen as a methodology to follow, much as one might use any 
other; it can also be seen as an approach that provides principles to be followed.  If one believes the 
former one approach would be to cease to use CASP and move over to GRADE entirely, however 
CASP remains popular and so it would seem premature to take such a step.  Another approach 
however would be to see GRADE as an approach and to use CASP within this.  A consensus 
approach by educators on this subject could refine this further, and perhaps a GRADE for education 
or GRADE-Ed Group for those interested in this area. 
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GRADE criteria CASP RCT question Comparison 
Three categories of outcomes 
according to importance for 
decision-making: critical; 
important but not critical; of 
limited importance.  
Did the trial address a clearly 
focused issue? 
Study and outcome-level factor 
– CASP equivalent; possible add 
is it a critical, important or 
question of limited importance? 
   
Study limitations/risk of bias 
Selective outcome reporting 
Were all clinically important 
outcomes considered? 
Study and outcome-level factor 
– CASP equivalent  
Study limitations/risk of bias 
Lack of allocation concealment 
Was the assignment of 
patients to treatments 
randomised? 
Study and outcome-level factor 
– CASP equivalent.  CASP asks 
explicitly about assessing 
randomisation  
Study limitations/risk of bias 
Incomplete accounting of 
patients and outcome events 
Were all of the patients 
who entered the trial 
properly accounted for at 
its conclusion? 
Study and outcome-level factor 
– CASP equivalent 
Study limitations/risk of bias 
Lack of blinding 
Were patients, health 
workers and study personnel 
‘blind’ to treatment? 
Aside from the experimental 
intervention, were the groups 
treated equally? 
Study and outcome-level factor 
– CASP equivalent 
Study limitations/risk of bias 
Other limitations 
Were the groups similar at 
the start of the trial? 
This is a study and outcome-
level factor, CASP asks 
explicitly about the presence of 
randomisaton 
Inconsistency of results  Outcome level factor – CASP 
has no direct equivalent 
Imprecision How precise was the estimate 
of the treatment effect? 
Study and outcome-level factor 
– CASP equivalent 
Indirectness of evidence Can the results be applied to 
the local population, or in 
your context? 
Study and outcome-level factor 
– CASP equivalent 
Publication bias  Outcome level factor – CASP 
has no direct equivalent 
   
Confidence in the magnitude of 
estimates of effect (overall 
quality of evidence for 
outcomes) 
 Study and outcome-level factor 
– CASP equivalent 





Are the benefits worth the 




Are the benefits worth the 
harms and costs? 
Outcome-level factor – CASP 
equivalent 
Confidence in values and 
preferences and their variability 
Are the benefits worth the 
harms and costs? 
Outcome level factor – CASP 
equivalent 
 










Criteria for determining whether the 
GRADE approach was used 
Application to this approach 
Definition of quality of evidence should be 
defined consistently with the GRADE 
definitions. For guideline panels: reflects the 
extent to which our confidence in an estimate of 
the effect is adequate to support a particular 
recommendation. 
Systematic reviews: reflects the extent to which 
we are confident that an estimate of the effect is 
correct. 
CASP contains items to assess confidence in 
study estimates 
Consideration given to each of the GRADE 
criteria for assessing the quality of evidence: 
risk of bias; directness of evidence; consistency 
and precision of results; risk of publication bias; 
magnitude of the effect; dose-response gradient, 
and influence of residual plausible confounding 
CASP does not currently consider consistency of 
results, publication bias or values and 
preferences which should be added for outcome-
level assessment 
Quality of evidence (confidence in the estimated 
effects) assessed for important outcomes and 
expressed using three (high, moderate, low) or 
four categories (high, moderate, low, very low) 
This is independent of the tool used 
Tables or detailed narrative summaries should be 
used as the basis for judgements about the 
quality of evidence and the strength of 
recommendations 
This is independent of the tool used 
Consideration given to each of the four  criteria 
for determining the strength of a 
recommendation (the balance of desirable and 
undesirable consequences, quality of evidence, 
values and preferences of those affected, and 
resource use)  
This is independent of the tool used 
Strength of recommendations expressed using 
two categories (weak and strong)  
This is independent of the tool used 
Decisions about the strength of  
recommendations transparently reported 
This is independent of the tool used 
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